BioCentury | Aug 29, 2011
Company News

Endeavour Capital Ltd., Florida Regional Center LLC other news

...to be completed by Jan. 2013. Companies in Endeavour's New Zealand portfolio include proteomics biotech Protemix Corp. Ltd....
BioCentury | Aug 3, 2009
Strategy

What might fit

...containing thiazide, atenolol, ramipril, simvastatin and aspirin Reduce risk factors for cardiovascular disease Ph II Protemix Corp. Ltd....
BioCentury | Aug 3, 2009
Strategy

Questions of the heart

...Rating (HAM-D) score in a Phase IIb trial for major depressive disorder (MDD). PX811019 from Protemix Corp. Ltd....
...to treat non-diabetic heart failure, as well. COO and CFO David Pool told BioCentury that Protemix...
...Inc. (NASDAQ:OSIP), Melville, N.Y. Palmetto Pharmaceuticals Inc. , Lexington, Mass. Pari GmbH , Starnberg, Germany Protemix Corp. Ltd....
BioCentury | Apr 5, 2007
Financial News

Protemix raises $14.5 million

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) raised US$14.5 million in the first closing...
...copper chelating agent has Fast Track designation in the U.S. Novartis Venture's Reinhard Ambros joined Protemix's...
BioCentury | Apr 2, 2007
Company News

Ardea management update

...Christopher Krueger as SVP and CBO, formerly SVP of business development and strategic alliances at Protemix Corp. Ltd....
BioCentury | Apr 10, 2006
Company News

Protemix board of directors update

Protemix Corp. Ltd. , Auckland, New Zealand Business: Cardiovascular, Metabolic Appointed: Alan Cherrington, professor of medicine at Vanderbilt University; and Daniel Petree, a partner at P2 Partners LLC WIR Staff...
BioCentury | Feb 6, 2006
Company News

Protemix board of directors update

Protemix Corp. Ltd. , Auckland, New Zealand Business: Cardiovascular, Metabolic Appointed: Jean-Pierre Millon, former CEO at PCS Health Systems Inc., as chairman WIR Staff Cardiovascular...
BioCentury | May 30, 2005
Clinical News

Laszarin trientine regulatory update

...diabetes. Laszarin is an orally-active small molecule that selectively chelates the oxidized form of copper. Protemix...
BioCentury | Feb 14, 2005
Company News

Protemix Corp. management update

Protemix Corp. , Auckland, New Zealand Business: Cardiovascular Hired: Larry Ellingson as CEO, while remaining a director of the American Diabetes Association WIR Staff Cardiovascular Endocrine / Metabolic...
BioCentury | Feb 8, 2005
Company News

Protemix names Ellingson CEO

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) hired Larry Ellingson as CEO. Ellingson, who...
...will remain a director of the association after June, when his term as chairman ends. Protemix's...
Items per page:
1 - 10 of 10
BioCentury | Aug 29, 2011
Company News

Endeavour Capital Ltd., Florida Regional Center LLC other news

...to be completed by Jan. 2013. Companies in Endeavour's New Zealand portfolio include proteomics biotech Protemix Corp. Ltd....
BioCentury | Aug 3, 2009
Strategy

What might fit

...containing thiazide, atenolol, ramipril, simvastatin and aspirin Reduce risk factors for cardiovascular disease Ph II Protemix Corp. Ltd....
BioCentury | Aug 3, 2009
Strategy

Questions of the heart

...Rating (HAM-D) score in a Phase IIb trial for major depressive disorder (MDD). PX811019 from Protemix Corp. Ltd....
...to treat non-diabetic heart failure, as well. COO and CFO David Pool told BioCentury that Protemix...
...Inc. (NASDAQ:OSIP), Melville, N.Y. Palmetto Pharmaceuticals Inc. , Lexington, Mass. Pari GmbH , Starnberg, Germany Protemix Corp. Ltd....
BioCentury | Apr 5, 2007
Financial News

Protemix raises $14.5 million

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) raised US$14.5 million in the first closing...
...copper chelating agent has Fast Track designation in the U.S. Novartis Venture's Reinhard Ambros joined Protemix's...
BioCentury | Apr 2, 2007
Company News

Ardea management update

...Christopher Krueger as SVP and CBO, formerly SVP of business development and strategic alliances at Protemix Corp. Ltd....
BioCentury | Apr 10, 2006
Company News

Protemix board of directors update

Protemix Corp. Ltd. , Auckland, New Zealand Business: Cardiovascular, Metabolic Appointed: Alan Cherrington, professor of medicine at Vanderbilt University; and Daniel Petree, a partner at P2 Partners LLC WIR Staff...
BioCentury | Feb 6, 2006
Company News

Protemix board of directors update

Protemix Corp. Ltd. , Auckland, New Zealand Business: Cardiovascular, Metabolic Appointed: Jean-Pierre Millon, former CEO at PCS Health Systems Inc., as chairman WIR Staff Cardiovascular...
BioCentury | May 30, 2005
Clinical News

Laszarin trientine regulatory update

...diabetes. Laszarin is an orally-active small molecule that selectively chelates the oxidized form of copper. Protemix...
BioCentury | Feb 14, 2005
Company News

Protemix Corp. management update

Protemix Corp. , Auckland, New Zealand Business: Cardiovascular Hired: Larry Ellingson as CEO, while remaining a director of the American Diabetes Association WIR Staff Cardiovascular Endocrine / Metabolic...
BioCentury | Feb 8, 2005
Company News

Protemix names Ellingson CEO

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) hired Larry Ellingson as CEO. Ellingson, who...
...will remain a director of the association after June, when his term as chairman ends. Protemix's...
Items per page:
1 - 10 of 10